Drug Profile
Formoterol/fluticasone propionate - Ache Laboratories
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Ache Laboratories
- Class Antiallergics; Antiasthmatics; Ethanolamines; Glucocorticoids; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists; Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Chronic obstructive pulmonary disease
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Chronic-obstructive-pulmonary-disease in Brazil (Inhalation, Aerosol)
- 18 Oct 2016 Ache withdraws a phase III trial for Chronic Obstructive Pulmonary Disease prior to enrolment in Brazil (NCT01393145)
- 15 Jul 2011 Clinical trials in Chronic obstructive pulmonary disease in Brazil (Inhalation)